1-4 of 4
Marian Ewell, ScD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Optimized Cyclophosphamide (CY) Dosing in Combination with Fludarabine, TBI and ATG As Conditioning for Unrelated Donor Bone Marrow Transplantation (BMT) in Severe Aplastic Anemia (SAA): A Phase I/II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)

Paolo Anderlini, MD, Juan Wu, MS, H. Joachim Deeg, MD, Iris Gersten, MS, Marian Ewell, ScD, Jakub Tolar, MD PhD, Joseph H. Antin, MD, Sally Arai, MD, Mitchell E. Horwitz, MD, John M. McCarty, MD, Ryotaro Nakamura, MD, Michael A. Pulsipher, MD, Roberta H. Adams, MD, Eric Leifer, PhD, Shelly L Carter, ScD, Nancy L DiFronzo, PhD, Mary M. Horowitz, MD MS, Dennis L. Confer, MD, Mary Eapen, MBBS, MS
Journal: Blood
Blood (2014) 124 (21): 541.
https://doi.org/10.1182/blood.V124.21.541.541
Published: 2014
Journal Articles

Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation From Unrelated Donors in Severe Aplastic Anemia (SAA): Serious and Unexpected Adverse Events in Pre-Defined Cyclophosphamide (CY) Dose Levels

Jakub Tolar, MD, PhD, H. Joachim Deeg, M.D., Sally Arai, MD, Mitchell Horwitz, MD, Joseph H. Antin, MD, John M. McCarty, MD, Roberta H. Adams, MD, Mary Eapen, MBBS, Marian Ewell, ScD, Eric Leifer, PhD, Iris Gersten, MS, Shelly L Carter, ScD, Mary M. Horowitz, MD, Dennis L Confer, MD, Ryotaro Nakamura, MD, Michael Pulsipher, MD, Nancy L DiFronzo, PhD, Paolo Anderlini, MD
Journal: Blood
Blood (2011) 118 (21): 3009.
https://doi.org/10.1182/blood.V118.21.3009.3009
Published: 2011
Journal Articles

Tandem Autologous Hematopoietic Stem Cell Transplants (AuHCT) with or without Maintenance Therapy (auto-auto) Versus Single AuHCT Followed by HLA Matched Sibling Non- Myeloablative Allogeneic HCT (auto-allo) for Patients with Standard Risk (SR) Multiple Myeloma (MM): Results From the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 Trial

Amrita Krishnan, M.D., Marcelo C Pasquini, MD, MS, Marian Ewell, ScD, Edward A. Stadtmauer, MD, Edwin P Alyea, III, MD, Joseph H. Antin, MD, Raymond L. Comenzo, MD, Stacey Goodman, MD, Parameswaran Hari, MD, Robert Negrin, MD, Muzaffar H. Qazilbash, MD, Scott D Rowley, Firoozeh Sahebi, George Somlo, MD, David H. Vesole, MD, PhD, Dan T. Vogl, MD, MSCE, Daniel J. Weisdorf, MD, Nancy Geller, PhD, Mary M. Horowitz, MD, MS, Sergio Giralt, MD, David G. Maloney
Journal: Blood
Blood (2010) 116 (21): 41.
https://doi.org/10.1182/blood.V116.21.41.41
Published: 2010
Journal Articles

Tandem Autologous Stem Cell Transplants (auto-auto) with or without Maintenance Therapy Versus Single Autologous Transplant Followed by HLA-Matched Sibling Non- Myeloablative Allogeneic Stem Cell Transplant (auto-allo) for Patients (pts) with High Risk (HR) Multiple Myeloma (MM): Results From the Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0102 Trial

Edward A Stadtmauer, MD, Amrita Krishnan, M.D., Marcelo C Pasquini, MD, MS, Marian Ewell, ScD, Edwin P Alyea, III, MD, Joseph H. Antin, MD, Hugo Castro-Malaspina, MD, Adetola A. Kassim, MD, MS, Robert Negrin, MD, Muzaffar H. Qazilbash, MD, J. Douglas Rizzo, MD, MS, Scott D Rowley, Firoozeh Sahebi, George Somlo, MD, David H. Vesole, MD, PhD, Dan T. Vogl, MD, MSCE, Daniel J. Weisdorf, MD, Nancy Geller, PhD, Mary M. Horowitz, MD, MS, David G. Maloney, Sergio Giralt, MD
Journal: Blood
Blood (2010) 116 (21): 526.
https://doi.org/10.1182/blood.V116.21.526.526
Published: 2010